Cargando…

Calcium-sensing receptor-mediated NLRP3 inflammasome response to calciprotein particles drives inflammation in rheumatoid arthritis

Increased extracellular Ca(2+) concentrations ([Ca(2+)](ex)) trigger activation of the NLRP3 inflammasome in monocytes through calcium-sensing receptor (CaSR). To prevent extraosseous calcification in vivo, the serum protein fetuin-A stabilizes calcium and phosphate into 70-100 nm-sized colloidal ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Jäger, Elisabeth, Murthy, Supriya, Schmidt, Caroline, Hahn, Magdalena, Strobel, Sarah, Peters, Anna, Stäubert, Claudia, Sungur, Pelin, Venus, Tom, Geisler, Mandy, Radusheva, Veselina, Raps, Stefanie, Rothe, Kathrin, Scholz, Roger, Jung, Sebastian, Wagner, Sylke, Pierer, Matthias, Seifert, Olga, Chang, Wenhan, Estrela-Lopis, Irina, Raulien, Nora, Krohn, Knut, Sträter, Norbert, Hoeppener, Stephanie, Schöneberg, Torsten, Rossol, Manuela, Wagner, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447633/
https://www.ncbi.nlm.nih.gov/pubmed/32843625
http://dx.doi.org/10.1038/s41467-020-17749-6
Descripción
Sumario:Increased extracellular Ca(2+) concentrations ([Ca(2+)](ex)) trigger activation of the NLRP3 inflammasome in monocytes through calcium-sensing receptor (CaSR). To prevent extraosseous calcification in vivo, the serum protein fetuin-A stabilizes calcium and phosphate into 70-100 nm-sized colloidal calciprotein particles (CPPs). Here we show that monocytes engulf CPPs via macropinocytosis, and this process is strictly dependent on CaSR signaling triggered by increases in [Ca(2+)](ex). Enhanced macropinocytosis of CPPs results in increased lysosomal activity, NLRP3 inflammasome activation, and IL-1β release. Monocytes in the context of rheumatoid arthritis (RA) exhibit increased CPP uptake and IL-1β release in response to CaSR signaling. CaSR expression in these monocytes and local [Ca(2+)] in afflicted joints are increased, probably contributing to this enhanced response. We propose that CaSR-mediated NLRP3 inflammasome activation contributes to inflammatory arthritis and systemic inflammation not only in RA, but possibly also in other inflammatory conditions. Inhibition of CaSR-mediated CPP uptake might be a therapeutic approach to treating RA.